Module 4: The specifics of advanced disease in MASLD
The EASL MALSD Guidelines Academy 2026, Module 4, will offer deep insights into advanced liver disease in MASLD and discuss challenges in diagnostics and clinical management. The module will aim to enhance participants’ understanding of the natural course of advanced MASLD and its complications and enhance participants’ practical clinical knowledge through interactive discussions with experts and case–based workshops.
Academy Organisers:
- Sona Frankova
- Jan Sperl
Please note that the programme is subject to change, and will be updated continuously up to the event.
Aims
- To offer a comprehensive insight into advanced MASLD and its complications.
- To provide a practical guidance on complex management of the challenges in MASLD.
- To facilitate peer collaboration through workshops.
Learning objectives
- Clinical considerations in the advanced stages of MASLD with the focus on cirrhosis and its complications.
- Specifics of diagnosis and monitoring in advanced stages of liver disease, including pitfalls in portal hypertension, transplant and bariatric surgery.
- Identification of cardiovascular risks.
- Management of sarcopenia, frailty and malnutrition.
- Selection of liver transplantation candidates.
Top 3 reasons to attend
- To enhance the ability to apply diagnostic and management strategies in advanced MASLD.
- To refine decision-making skills and learn from diverse expert perspectives.
- To strengthen multidisciplinary collaboration that translates into improved patient care and confident clinical practice.
Target audience
- Gastroenterology and Hepatology trainees.
- Liver transplant hepatologists.
- Medical professionals taking care of MASLD patients (diabetologists, obesitologists, etc.).
